| - GRCh37:
- Chr5:149360488
- GRCh38:
- Chr5:149980925
| SLC26A2 | | Multiple epiphyseal dysplasia type 4, Achondrogenesis, type IB, Diastrophic dysplasia, Atelosteogenesis type II | Likely benign (Oct 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357216-149361376
| SLC26A2 | | Achondrogenesis, type IB, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II, Diastrophic dysplasia | Pathogenic (Aug 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357626
- GRCh38:
- Chr5:149978063
| SLC26A2 | | Multiple epiphyseal dysplasia type 4, Achondrogenesis, type IB, Diastrophic dysplasia, Atelosteogenesis type II | Likely benign (Oct 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360353
- GRCh38:
- Chr5:149980790
| SLC26A2 | | Multiple epiphyseal dysplasia type 4, Achondrogenesis, type IB, Diastrophic dysplasia, Atelosteogenesis type II | Likely benign (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360081
- GRCh38:
- Chr5:149980518
| SLC26A2 | L309F | Achondrogenesis, type IB, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II, Diastrophic dysplasia | Uncertain significance (Oct 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357783
- GRCh38:
- Chr5:149978220
| SLC26A2 | S190G | Achondrogenesis, type IB, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II, Diastrophic dysplasia | Uncertain significance (Jul 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360603
- GRCh38:
- Chr5:149981040
| SLC26A2 | L483F | Achondrogenesis, type IB, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II, Diastrophic dysplasia | Uncertain significance (Jul 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149359935
- GRCh38:
- Chr5:149980372
| SLC26A2 | A260V | Achondrogenesis, type IB, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II, Diastrophic dysplasia | Uncertain significance (Feb 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360953
- GRCh38:
- Chr5:149981390
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Multiple epiphyseal dysplasia type 4, Diastrophic dysplasia | Likely benign (Aug 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149359862
- GRCh38:
- Chr5:149980299
| SLC26A2 | M236V | Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II, Achondrogenesis, type IB | Uncertain significance (Jun 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357842
- GRCh38:
- Chr5:149978279
| SLC26A2 | D209E | Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II, Achondrogenesis, type IB | Uncertain significance (Sep 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357850
- GRCh38:
- Chr5:149978287
| SLC26A2 | C212F | Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II, Achondrogenesis, type IB | Uncertain significance (Jun 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360975
- GRCh38:
- Chr5:149981412
| SLC26A2 | I607V | Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II, Achondrogenesis, type IB | Uncertain significance (Mar 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360697
- GRCh38:
- Chr5:149981134
| SLC26A2 | I514T | Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II, Achondrogenesis, type IB | Uncertain significance (Jun 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360826
- GRCh38:
- Chr5:149981263
| SLC26A2 | V557A | Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II, Achondrogenesis, type IB, Inborn genetic diseases | Uncertain significance (May 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:149360995-149360997
- GRCh38:
- Chr5:149981432-149981434
| SLC26A2 | K615del | Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II, Achondrogenesis, type IB | Uncertain significance (Jan 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360089
- GRCh38:
- Chr5:149980526
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Likely benign (May 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360561
- GRCh38:
- Chr5:149980998
| SLC26A2 | L469V | Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II, Achondrogenesis, type IB | Uncertain significance (Feb 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357284
- GRCh38:
- Chr5:149977721
| SLC26A2 | P24fs | Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II, Achondrogenesis, type IB | Pathogenic (Sep 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360608
- GRCh38:
- Chr5:149981045
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Likely benign (Sep 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149361148
- GRCh38:
- Chr5:149981585
| SLC26A2 | I664M | Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II, Achondrogenesis, type IB | Uncertain significance (Jun 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360895
- GRCh38:
- Chr5:149981332
| SLC26A2 | I580T | Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II, Achondrogenesis, type IB | Uncertain significance (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149361221
- GRCh38:
- Chr5:149981658
| SLC26A2 | T689A | Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II, Achondrogenesis, type IB | Uncertain significance (Jul 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357749
- GRCh38:
- Chr5:149978186
| SLC26A2 | | Achondrogenesis, type IB, Diastrophic dysplasia, Atelosteogenesis type II, Multiple epiphyseal dysplasia type 4 | Likely benign (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357289
- GRCh38:
- Chr5:149977726
| SLC26A2 | S25C | Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II, Achondrogenesis, type IB | Uncertain significance (Dec 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360420
- GRCh38:
- Chr5:149980857
| SLC26A2 | G422S | Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II, Achondrogenesis, type IB | Uncertain significance (Apr 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357910
- GRCh38:
- Chr5:149978347
| SLC26A2 | Y232C | Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II, Achondrogenesis, type IB | Uncertain significance (Jun 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360642
- GRCh38:
- Chr5:149981079
| SLC26A2 | R496C | Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II, Achondrogenesis, type IB | Uncertain significance (Feb 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149361292
- GRCh38:
- Chr5:149981729
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Likely benign (May 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357287
- GRCh38:
- Chr5:149977724
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Likely benign (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360271
- GRCh38:
- Chr5:149980708
| SLC26A2 | K372R | Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II, Achondrogenesis, type IB | Uncertain significance (May 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360196
- GRCh38:
- Chr5:149980633
| SLC26A2 | S347F | Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II, Achondrogenesis, type IB | Uncertain significance (Sep 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360720
- GRCh38:
- Chr5:149981157
| SLC26A2 | S522P | Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II, Achondrogenesis, type IB | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149361095
- GRCh38:
- Chr5:149981532
| SLC26A2 | H647Y | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Inborn genetic diseases | Uncertain significance (Jan 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:149357310
- GRCh38:
- Chr5:149977747
| SLC26A2 | Q32L | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Uncertain significance (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360637
- GRCh38:
- Chr5:149981074
| SLC26A2 | A494V | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Uncertain significance (Apr 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357377
- GRCh38:
- Chr5:149977814
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Likely benign (May 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360938
- GRCh38:
- Chr5:149981375
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Likely benign (Dec 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360595
- GRCh38:
- Chr5:149981032
| SLC26A2 | K480R | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Uncertain significance (Jan 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149361167
- GRCh38:
- Chr5:149981604
| SLC26A2 | R671C | Inborn genetic diseases, Achondrogenesis, type IB, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II | Uncertain significance (Jan 23, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:149360593
- GRCh38:
- Chr5:149981030
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Likely benign (Oct 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357767
- GRCh38:
- Chr5:149978204
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Likely benign (Oct 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149361054
- GRCh38:
- Chr5:149981491
| SLC26A2 | D633V | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Uncertain significance (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360146-149360148
- GRCh38:
- Chr5:149980583-149980585
| SLC26A2 | A331del | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Uncertain significance (Mar 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149361302
- GRCh38:
- Chr5:149981739
| SLC26A2 | M716V | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Uncertain significance (Nov 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360880
- GRCh38:
- Chr5:149981317
| SLC26A2 | K575R | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Uncertain significance (Jan 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149361174
- GRCh38:
- Chr5:149981611
| SLC26A2 | D673V | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357684
- GRCh38:
- Chr5:149978121
| SLC26A2 | S157T | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Uncertain significance (Jul 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149361241-149361242
- GRCh38:
- Chr5:149981678-149981679
| SLC26A2 | N696fs | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Pathogenic (Apr 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360440
- GRCh38:
- Chr5:149980877
| SLC26A2 | | Achondrogenesis, type IB, Multiple epiphyseal dysplasia type 4, Diastrophic dysplasia, Atelosteogenesis type II | Likely benign (Apr 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149361103
- GRCh38:
- Chr5:149981540
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Likely benign (Apr 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360705
- GRCh38:
- Chr5:149981142
| SLC26A2 | V517L | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Uncertain significance (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357506
- GRCh38:
- Chr5:149977943
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Likely benign (Mar 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357845
- GRCh38:
- Chr5:149978282
| SLC26A2 | R210S | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Uncertain significance (Mar 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360486
- GRCh38:
- Chr5:149980923
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Likely benign (Mar 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357333
- GRCh38:
- Chr5:149977770
| SLC26A2 | K40* | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Pathogenic (Mar 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357429
- GRCh38:
- Chr5:149977866
| SLC26A2 | K72* | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Pathogenic (Sep 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149359995-149359996
- GRCh38:
- Chr5:149980432-149980433
| SLC26A2 | N281* | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Pathogenic (Feb 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360955-149360958
- GRCh38:
- Chr5:149981392-149981395
| SLC26A2 | Q602fs | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Pathogenic (Feb 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360989
- GRCh38:
- Chr5:149981426
| SLC26A2 | | Achondrogenesis, type IB, Diastrophic dysplasia, Atelosteogenesis type II, Multiple epiphyseal dysplasia type 4 | Likely benign (Feb 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360662
- GRCh38:
- Chr5:149981099
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Likely benign (Feb 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360710
- GRCh38:
- Chr5:149981147
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Likely benign (Feb 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357420
- GRCh38:
- Chr5:149977857
| SLC26A2 | F69L | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Uncertain significance (Feb 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149359848
- GRCh38:
- Chr5:149980285
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Likely benign (Oct 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360136
- GRCh38:
- Chr5:149980573
| SLC26A2 | S327F | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Uncertain significance (Jun 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360923
- GRCh38:
- Chr5:149981360
| SLC26A2 | Y589* | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Pathogenic (Jan 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357832
- GRCh38:
- Chr5:149978269
| SLC26A2 | H206R | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Uncertain significance (Aug 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149361280
- GRCh38:
- Chr5:149981717
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Likely benign (Feb 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357775
- GRCh38:
- Chr5:149978212
| SLC26A2 | N187S | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Uncertain significance (Mar 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360257
- GRCh38:
- Chr5:149980694
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Multiple epiphyseal dysplasia type 4, Diastrophic dysplasia | Likely benign (Jan 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357585
- GRCh38:
- Chr5:149978022
| SLC26A2 | P124T | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Uncertain significance (Dec 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357332
- GRCh38:
- Chr5:149977769
| SLC26A2 | F39L | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Uncertain significance (Mar 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149361216
- GRCh38:
- Chr5:149981653
| SLC26A2 | N687S | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Uncertain significance (Oct 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357596
- GRCh38:
- Chr5:149978033
| SLC26A2 | I127M | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Uncertain significance (Dec 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357865
- GRCh38:
- Chr5:149978302
| SLC26A2 | Y217C | Inborn genetic diseases, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4, Achondrogenesis, type IB | Uncertain significance (May 30, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:149361370-149361377
- GRCh38:
- Chr5:149981807-149981814
| SLC26A2 | D739fs | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Uncertain significance (Jun 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149361193
- GRCh38:
- Chr5:149981630
| SLC26A2 | I679M | Atelosteogenesis type II, Achondrogenesis, type IB, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Uncertain significance (Aug 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357380
- GRCh38:
- Chr5:149977817
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Likely benign (Dec 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360572
- GRCh38:
- Chr5:149981009
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Likely benign (Dec 25, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360421
- GRCh38:
- Chr5:149980858
| SLC26A2 | G422A | Atelosteogenesis type II, Achondrogenesis, type IB, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360785
- GRCh38:
- Chr5:149981222
| SLC26A2 | L544fs | Atelosteogenesis type II, Achondrogenesis, type IB, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Pathogenic (Apr 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360020
- GRCh38:
- Chr5:149980457
| SLC26A2 | | Achondrogenesis, type IB, Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II, Diastrophic dysplasia | Likely benign (May 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360530
- GRCh38:
- Chr5:149980967
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Likely benign (Oct 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360521
- GRCh38:
- Chr5:149980958
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Likely benign (Oct 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149361106
- GRCh38:
- Chr5:149981543
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Likely benign (Oct 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357319
- GRCh38:
- Chr5:149977756
| SLC26A2 | S35* | Atelosteogenesis type II, Achondrogenesis, type IB, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Pathogenic (Sep 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360509
- GRCh38:
- Chr5:149980946
| SLC26A2 | | Achondrogenesis, type IB, Diastrophic dysplasia, Atelosteogenesis type II, Multiple epiphyseal dysplasia type 4 | Likely benign (Sep 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357773
- GRCh38:
- Chr5:149978210
| SLC26A2 | | Achondrogenesis, type IB, Diastrophic dysplasia, Atelosteogenesis type II, Multiple epiphyseal dysplasia type 4 | Likely benign (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357605
- GRCh38:
- Chr5:149978042
| SLC26A2 | | Achondrogenesis, type IB, Diastrophic dysplasia, Atelosteogenesis type II, Multiple epiphyseal dysplasia type 4 | Likely benign (Aug 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149361264
- GRCh38:
- Chr5:149981701
| SLC26A2 | E704fs | Atelosteogenesis type II, Achondrogenesis, type IB, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Pathogenic (Aug 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360797
- GRCh38:
- Chr5:149981234
| SLC26A2 | | Achondrogenesis, type IB, Diastrophic dysplasia, Atelosteogenesis type II, Multiple epiphyseal dysplasia type 4 | Likely benign (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360812
- GRCh38:
- Chr5:149981249
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Multiple epiphyseal dysplasia type 4, Diastrophic dysplasia | Likely benign (Aug 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357635
- GRCh38:
- Chr5:149978072
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Multiple epiphyseal dysplasia type 4, Diastrophic dysplasia | Likely benign (Dec 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360386
- GRCh38:
- Chr5:149980823
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Multiple epiphyseal dysplasia type 4, Diastrophic dysplasia | Likely benign (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149361034
- GRCh38:
- Chr5:149981471
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Multiple epiphyseal dysplasia type 4, Diastrophic dysplasia | Likely benign (Mar 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357866
- GRCh38:
- Chr5:149978303
| SLC26A2 | | Achondrogenesis, type IB, Atelosteogenesis type II, Multiple epiphyseal dysplasia type 4, Diastrophic dysplasia | Likely benign (Jul 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360499
- GRCh38:
- Chr5:149980936
| SLC26A2 | S448* | Atelosteogenesis type II, Achondrogenesis, type IB, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Pathogenic (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149361169
- GRCh38:
- Chr5:149981606
| SLC26A2 | | Multiple epiphyseal dysplasia type 4, Achondrogenesis, type IB, Diastrophic dysplasia, Atelosteogenesis type II | Likely benign (Jun 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149357825
- GRCh38:
- Chr5:149978262
| SLC26A2 | L204V | Atelosteogenesis type II, Achondrogenesis, type IB, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Uncertain significance (Jun 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149360584
- GRCh38:
- Chr5:149981021
| SLC26A2 | Y476* | Atelosteogenesis type II, Achondrogenesis, type IB, Diastrophic dysplasia, Multiple epiphyseal dysplasia type 4 | Pathogenic (Jun 3, 2022) | criteria provided, single submitter |